MyFinsight
Home
Blog
About
Proceeds issue of common
stock-Registered Direct Offering
$16,845K
Proceeds exercise of
stock options
$1K
(-92.31%↓ Y/Y)
Net cash flows
provided by financing...
$16,846K
(-47.19%↓ Y/Y)
Net (decrease)
increase in cash
$5,528K
(-36.93%↓ Y/Y)
Canceled cashflow
$11,318K
Stock-based
compensation-Lucid...
$1,680K
Accrued expenses and
other current...
$243K
(159.71%↑ Y/Y)
Depreciation and
amortization expense
$224K
(-49.44%↓ Y/Y)
Prepaid expenses and
other current assets
-$52K
(-105.52%↓ Y/Y)
Amortization of common stock
payment for vendor...
$28K
(-80.95%↓ Y/Y)
Stock-based
compensation-Pavmed2014Equity Plan
$13K
Net cash flows used
in operating...
-$11,297K
(50.91%↑ Y/Y)
Net cash flows used
in investing...
-$21K
(82.20%↑ Y/Y)
Canceled cashflow
$2,240K
Net loss
-$11,687K
(62.72%↑ Y/Y)
Purchase of equipment
$21K
(-82.20%↓ Y/Y)
Change in fair value -
senior secured...
$1,040K
(-86.38%↓ Y/Y)
Accounts receivable
$399K
(21.65%↑ Y/Y)
Back
Back
Cash Flow
Lucid Diagnostics Inc. (LUCD)
Lucid Diagnostics Inc. (LUCD)
source: myfinsight.com